These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 13140189)
21. [Degradation of chymotrypsinogen by chymotrypsin]. ROVERY M; POILROUX M; YOSHIDA A; DESNUELLE P Biochim Biophys Acta; 1957 Mar; 23(3):608-20. PubMed ID: 13426173 [No Abstract] [Full Text] [Related]
22. A spectrophotometric determination of trypsin and chymotrypsin. SCHWERT GW; TAKENAKA Y Biochim Biophys Acta; 1955 Apr; 16(4):570-5. PubMed ID: 14389277 [No Abstract] [Full Text] [Related]
23. Studies on proteolytic enzymes. I. Toxicology of crystalline trypsin and chymotrypsin. HENDLEY CD; ROBBINS KC; DERTINGER B; CLEMENTS GR; ERCOLI N Arch Int Pharmacodyn Ther; 1956 Apr; 106(1-2):164-77. PubMed ID: 13328223 [No Abstract] [Full Text] [Related]
24. The cytologic diagnosis of gastric cancer by chymotrypsin lavage. KLAYMAN MI; MASSEY BW; PLETICKA S; GALAMBOS JT; BRANDBORG L; KIRSNER JB; PALMER WL Gastroenterology; 1955 Nov; 29(5):849-53. PubMed ID: 13270813 [No Abstract] [Full Text] [Related]
25. [Preliminary observations on the conversion of chymotrypsinogen to chymotrypsin-alpha]. ROVERY M; POILROUX M; CURNIER A; DESNUELLE P Biochim Biophys Acta; 1955 Dec; 18(4):571-3. PubMed ID: 13304046 [No Abstract] [Full Text] [Related]
31. Chymotrypsin as a debriding agent. PRUETER RD; STEIN M; DRUM JA; KALZ F Can Med Assoc J; 1957 Jun; 76(12):1040-3. PubMed ID: 13437249 [No Abstract] [Full Text] [Related]
32. Reactivation of alpha-chymotrypsin inhibited by organic phosphates. CUNNINGHAM LW; NEURATH H Biochim Biophys Acta; 1953 Jun; 11(2):310. PubMed ID: 13081609 [No Abstract] [Full Text] [Related]
33. A manometric assay for chymotrypsin. PARKS RE; PLAUT GW J Biol Chem; 1953 Aug; 203(2):755-61. PubMed ID: 13084644 [No Abstract] [Full Text] [Related]
34. Stability of chymotrypsin and tobacco mosaic virus decreased by ultraviolet radiation. KLECZKOWSKI A Biochem J; 1954 Feb; 56(2):345-9. PubMed ID: 13140199 [No Abstract] [Full Text] [Related]
35. [The probable existence of a chymotrypsin lacking an N-terminal alanine molecule]. ROVERY M; DESNUELLE P Biochim Biophys Acta; 1954 Feb; 13(2):300-1. PubMed ID: 13140334 [No Abstract] [Full Text] [Related]
36. [On the mechanism of the anti-edema effect of parenteral crystalline proteases]. VEREMEENKO KN Vopr Med Khim; 1962; 8():525-31. PubMed ID: 13996746 [No Abstract] [Full Text] [Related]
37. Atypical deacylation of the acyl enzymes formed in the reaction of -chymotrypsin with bis(4-nitrophenyl) carbonate and 0-(4-nitrophenylene) carbonate. Fife TH; Hutchins JE; McMahon DM J Am Chem Soc; 1972 Feb; 94(4):1316-23. PubMed ID: 5060275 [No Abstract] [Full Text] [Related]
38. The cytologic diagnosis of gastric cancer of chymotrypsin lavage. II. The detection of early malignancy. KLAYMAN MI; MASSEY BW; PLETICKA S; GALAMBOS JT; BRANDBORG L; KIRSNER JB; PALMER WL Gastroenterology; 1955 Nov; 29(5):854-64. PubMed ID: 13270814 [No Abstract] [Full Text] [Related]
40. The number of catalytically active sites present on the chymotrypsin molecule. LOEWUS MW; BRIGGS DR J Biol Chem; 1952 Dec; 199(2):857-64. PubMed ID: 13022693 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]